EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Change in Acquisitions & Divestments (2010 - 2026)

EyePoint (EYPT) posted Change in Acquisitions & Divestments of $70.0 million for Q1 2026, down 6.67% sequentially from $75.0 million in Q4 2025, and down 11.64% YoY from $79.2 million in Q1 2025.

Analysis

EyePoint (EYPT) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

EyePoint has reported Change in Acquisitions & Divestments for 13 years, with the latest figure at $70.0 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 11.64% year-over-year to $70.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $314.5 million (up 30.92% YoY) and the FY2025 annual result came in at $323.7 million, up 76.9% from the prior year.
  • Change in Acquisitions & Divestments eased to $70.0 million in Q1 2026 per EYPT's latest filing, from $75.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $103.5 million in Q2 2025 and troughed at $3.0 million in Q4 2023.
  • A 5-year average of $47.3 million and a median of $44.0 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments plunged 93.62% in 2023, then jumped 2183.33% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $47.0 million in 2022, then slumped by 93.62% to $3.0 million in 2023, then surged by 2183.33% to $68.5 million in 2024, then climbed by 9.49% to $75.0 million in 2025, then slipped by 6.67% to $70.0 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $70.0 million, $75.0 million, and $66.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75.00 Mn
Mar 31, 2026 70.00 Mn
Dec 31, 2025 75.00 Mn
Sep 30, 2025 66.00 Mn
Jun 30, 2025 103.50 Mn
Mar 31, 2025 79.23 Mn
Dec 31, 2024 68.50 Mn
Sep 30, 2024 67.00 Mn
Jun 30, 2024 25.50 Mn
Mar 31, 2024 22.00 Mn
Dec 31, 2023 3.00 Mn
Jun 30, 2023 16.78 Mn
Mar 31, 2023 35.50 Mn
Dec 31, 2022 47.00 Mn
Sep 30, 2022 41.00 Mn
Jun 30, 2022 30.00 Mn
Mar 31, 2022 6.00 Mn
Jun 30, 2017 2.50 Mn
Mar 31, 2017 3.35 Mn
Dec 31, 2016 5.39 Mn